Compounding the nation's severe shortage of execution drugs, federal authorities have confiscated shipments of a lethal-injection chemical that Arizona and Texas tried to bring in from abroad, saying such imports are illegal.
The Food and Drug Administration said yesterday that it impounded orders of sodium thiopental, an anesthetic that has been used in past executions in combination with drugs that paralyse the muscles and stop the heart. It currently has no legal uses in the US.
"Courts have concluded that sodium thiopental for the injection in humans is an unapproved drug and may not be imported into the country," FDA spokesman Jeff Ventura said in a statement.
Also Read
Arizona paid nearly USD 27,000 for the sodium thiopental, but federal agents intercepted it when it arrived via British Airways at the Phoenix airport in July, according to documents obtained by The Associated Press.
Texas and FDA authorities gave fewer details about the seizure there. Texas is the nation's busiest death penalty state, with about 250 death row inmates and 530 executions carried out over the past four decades. But it has not been using sodium thiopental in recent years.
The shortage of execution chemicals has become more acute over the past few years, ever since European companies started refusing to sell them to the US. Death penalty states have been scrambling to secure supplies, a search that in at least one case has taken them to India and a forlorn-looking business in a residential neighbourhood.
States have had to change drug combinations or put executions on hold while they look for other options.
Tennessee brought back the electric chair as a backup method, and Utah did the same with the firing squad. Other states have also looked into buying drugs from international pharmacies.
Ohio, which has halted executions until at least 2017 because of a lack of drugs, sent a letter earlier this month to the FDA asserting that the state believes it can obtain a lethal-injection drug overseas without violating any laws.
Nebraska ran afoul of the FDA earlier this year when the agency said it could not legally import sodium thiopental and a second lethal-injection chemical it had bought for USD 54,400 from Harris Pharma, a distributor in India.
That shipment apparently never made it to the United States.
"Just wanted to let you know have a few states who have already ordered sodium thiopental. Would Nebraska be interested as I will have a few thousand vials extra," Chris Harris, CEO of Harris Pharma, wrote in April to Nebraska officials, who released the correspondence under a public records request.
Harris did not name those states, and no one answered the door at the residential address in Kolkata, India, that is listed as the firm's office.
Key details are blacked out of the Arizona documents, which were released as part of a lawsuit against the corrections department over transparency in executions, and it is not clear what country or company the state was doing business with.
But, down to the font and formatting, the paperwork for the purchase resembles the Nebraska paperwork involving Harris Pharma.
A lawyer who has challenged Texas' death row practices questioned why any state would want to run the risk of a botched execution by buying drugs from an overseas supplier whose manufacturing standards are not well known.
